Article
Next-generation sequencing as a second-tier diagnostic test for newborn screening.
Journal of pediatric endocrinology & metabolism : JPEM - 28 Aug 2018
Luo Xiaomei, Wang Ruifang, Fan Yanjie, Gu Xuefan, Yu Yongguo
Abstract excerpt
Background Tandem mass spectrometry (MS/MS) has been used for newborn screening (NBS) of inherited metabolic diseases (IMDs) for decades. However, the traditional approach can yield false-positive or false-negative results and is affected by biochemical substrate-level fluctuations. To overcome the current limitations, we explored the possibility of using next-generation sequencing (NGS) as a second-tier...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
